Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data

OBJECTIVE: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. MATERIALS AND METHODS: A total of 136 patients (mean age ± standard deviation: 64.6±10.3 years, 66.9% males) who had received...

Descripción completa

Detalles Bibliográficos
Autores principales: Tombak, Anıl, Pepedil Tanrıkulu, Funda, Durusoy, Salih Sertaç, Dinçyürek, Hüseyin Derya, Kaya, Emin, Ümit, Elif Gülsüm, Yavaşoğlu, İrfan, Mehtap, Özgür, Deveci, Burak, Özcan, Mehmet Ali, Terzi, Hatice, Okay, Müfide, Sayınalp, Nilgün, Yılmaz, Mehmet, Okan, Vahap, Kızıklı, Alperen, Özcan, Ömer, Çetin, Güven, Demircioğlu, Sinan, Aydoğdu, İsmet, Saydam, Güray, Davulcu, Eren Arslan, İlhan, Gül, Uçar, Mehmet Ali, Özet, Gülsüm, Akpınar, Seval, Turgut, Burhan, Berber, İlhami, Kurtoğlu, Erdal, Sönmez, Mehmet, Batur, Derya Selim, Yıldırım, Rahşan, Özkocamaz, Vildan, Güneş, Ahmet Kürşad, Sahip, Birsen, Ertop, Şehmus, Akay, Olga Meltem, Baştürk, Abdülkadir, Doğu, Mehmet Hilmi, Akdeniz, Aydan, Ünal, Ali, Seyhanlı, Ahmet, Gürkan, Emel, Çekdemir, Demet, Ferhanoğlu, Burhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656120/
https://www.ncbi.nlm.nih.gov/pubmed/34448556
http://dx.doi.org/10.4274/tjh.galenos.2021.2021.0007

Ejemplares similares

Ejemplares similares